ROYAL BANK OF CANADA - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 31 filers reported holding ACER THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
376
-44.9%
0.00%
Q2 2023$1,000682
+5146.2%
0.00%
Q3 2022$013
-87.0%
0.00%
Q2 2021$01000.0%0.00%
Q1 2021$0
-100.0%
100
-95.0%
0.00%
Q3 2020$6,000
-33.3%
2,001
-24.8%
0.00%
Q2 2020$9,000
+350.0%
2,660
+154.5%
0.00%
Q1 2020$2,000
+100.0%
1,045
+277.3%
0.00%
Q4 2019$1,000277
+855.2%
0.00%
Q3 2019$029
-68.5%
0.00%
Q2 2019$0
-100.0%
92
-92.9%
0.00%
Q1 2019$31,0001,296
+25820.0%
0.00%
Q3 2018$050.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Nantahala Capital Management 1,136,416$1,049,3670.10%
Anson Funds Management LP 129,795$119,8530.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 60,000$550.01%
Hudson Bay Capital Management LP 274,300$253,2890.00%
UBS Group AG 33$300.00%
RHUMBLINE ADVISERS 347$3200.00%
OSAIC HOLDINGS, INC. 200$1840.00%
WELLS FARGO & COMPANY/MN 132$1220.00%
NORTHERN TRUST CORP 22,231$20,5280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACER THERAPEUTICS INC shareholders